OptimizeRx (OPRX) Equity Ratio (2016 - 2026)
OptimizeRx's Equity Ratio history spans 16 years, with the latest figure at 0.73 for Q4 2025.
- On a quarterly basis, Equity Ratio rose 6.09% to 0.73 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.73, a 6.09% increase, with the full-year FY2025 number at 0.73, up 6.09% from a year prior.
- Equity Ratio hit 0.73 in Q4 2025 for OptimizeRx, up from 0.72 in the prior quarter.
- Over the last five years, Equity Ratio for OPRX hit a ceiling of 0.96 in Q1 2021 and a floor of 0.68 in Q4 2024.
- Historically, Equity Ratio has averaged 0.84 across 5 years, with a median of 0.93 in 2022.
- Biggest five-year swings in Equity Ratio: increased 23.11% in 2021 and later fell 26.67% in 2024.
- Tracing OPRX's Equity Ratio over 5 years: stood at 0.93 in 2021, then grew by 0.51% to 0.94 in 2022, then decreased by 26.31% to 0.69 in 2023, then fell by 0.96% to 0.68 in 2024, then increased by 6.09% to 0.73 in 2025.
- Business Quant data shows Equity Ratio for OPRX at 0.73 in Q4 2025, 0.72 in Q3 2025, and 0.7 in Q2 2025.